GENEVA, September 4 /PRNewswire/ -- - Merck Serono and Ablynx to Equally Contribute to Discover and Develop Nanobodies(R) Against two Targets in Oncology and Immunology and Equally Share the…

Down Syndrome (DS) belongs to the group of conditions called 'aneuploidies', defined by an abnormal loss or gain of genetic material, i.e. fragments of chromosomes or whole chromosomes. Aneuploidies…

GENEVA, Switzerland, September 3 /PRNewswire/ -- - Merck Serono Now Has Exclusive Worldwide Development and Commercialisation Rights to atacicept, Including in North America Merck Serono, a division…

MUNICH, Germany, September 3 /PRNewswire/ -- A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new…

MUNICH, Germany, September 3 /PRNewswire/ -- - ACAPULCO study showed that 10 mg Prasugrel Maintenance Dose Achieved Higher Platelet Inhibition than 150 mg Clopidogrel Maintenance Dose Among patients…

Today there is rapidly growing interest in 'intelligent' computer-based methods that use various classes of measurement signals, from different patient samples, for instance, to create a model for…

A man's height is a marker for risk of prostate cancer development but is more strongly linked to progression of the cancer, say a group of British researchers who conducted their own study and also…

Researchers from Oregon State University say they have resolved a controversy that cellular biologists have been arguing over for nearly 50 years, with findings that may aid research on everything…

CALGARY, Canada, September 2 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S. Food and Drug Administration (FDA) review, the Company…

BURGESS HILL, England, September 1 /PRNewswire/ -- With some 20,000 UK children with Type 1 diabetes(i) about to start the new school year, new guidance from the National Institute for Health and…